TP53 and plasma cell myeloma: For example, consistent with our finding that FO treatment was associated with elevated expression of circulating miR-34a-5p, EPA and DHA may modulate the activation of p53/miR-34a-5p/Bcl-12 axis in myeloma cells [46].